Welcome to Prospect - a support group for prostate cancer patients, their wives, partners and carers.
Prospect is run by prostate cancer survivors for the benefit of the communities in Bristol and surrounding districts

  • Spring walk and lunch next

    The next members’ gathering will be the spring walk. It will be on Saturday May 4 around Kings Weston and will be 2.5mls (4km) with superb views over the Avon. Chris Millett, our professional walks leader, is also a botanist so come and brush up on your knowledge wild flowers. Meet at Morgans Café, Kings Weston House, Kings Weston Lane BS11 0UR, at 11am for coffee beforehand and, on return, lunch at 2pm. Booking is essential. For more details contact chrismillett2@gmail.com or via 07721 436318. Our first members’ meeting of 2019 got off to a lively start with the talk on PSA testing. Links can be found here to YouTube videos about the findings of the research mentioned.

    Coffee mornings held at the Macmillan Centre, Southmead Hospital, on the first Thursday of each month (10am-12.30), to help new patients. To help out, contact our chairman.

  • Sharks ‘might help beat cancer’

    Great white sharks might hold the secrets to curing cancer and other diseases, experts believe – BBC News (Feb ’19). More here

  • Help with treatment – but beware

    AN NHS tool is now available – intended for men with non-metastatic prostate cancer who are deciding between conservative and radical management regimes. It is intended only for men with non-metastatic prostate cancer who are deciding between conservative and radical management regimes. It’s recommend that patients use this tool in consultation with their doctor (Apr ’19). See here. You may have read about this tool in newspapers, but not all the news was 100% accurate – check this NHS Behind The Headlines Page for the facts.. And four new technologies that will tame the immune system are getting us closer to a future where cancer becomes curable. See more here

  • Cancer survival rates published


    Public Health England has published a statistical bulletin on survival rates (1-year and 5-year) for many types of cancer based on more recent data than previously available. If PCa is diagnosed at stages 1, 2 or 3, the 1-year survival rate is as good as for everyone else and the 5-year rate is the same for stages 1 and 2 (>96% for stage 3). Hence the importance of early diagnosis. A summary of the stats is to be found here with a link to the full report

  • Sparing nerves to avoid ED

    A trial to spare the nerves around the prostate during surgery is being held at Southmead Hospital. if successful will reduce the risk of erectile disfunction and will be available throughout England. The trial featured on BBC Points West on January 23 ’19.

  • Tool ‘could stop ops’

    Thousands of prostate cancer patients could be spared surgery as experts create a tool that calculates their risk of dying from the disease with 90 per cent accuracy. See here

  • Jab ‘game changer’

    A radical new treatment for prostate cancer in which tumour injections boost the immune system to kill malignant cells has been hailed as a potential ‘game-changer’ (Dec ’18).  See here

  • Boost in prostate cases

    Hospitals are treating more prostate cancer cases, partly thanks to celebrities raising awareness of the disease by speaking out about their own experiences, says the NHS head. Simon Stevens thanked broadcasters Bill Turnbull and Stephen Fry for urging men to seek help (Oct ’18). See here.

  • iKnife sniffs out cancer

    See a Cancer Research UK video about this remarkable surgical tool (Sept ’18).

  • MRI scandal – and spit test trial

    Half of men are being denied access to the life-saving advanced MRI scan technique to spot prostate cancer, a Prostate Cancer UK investigation has found. Freedom of information requests to hospitals and health boards found that only 51 per cent of men have access to the scans. The responses also uncovered evidence of discrimination against older men. Prostate Cancer UK said the situation was ‘appalling’ (Jun ’18). See. And a “very significant” spit test to detect men at increased risk of prostate cancer has started trials with 300 men taking part in London. Developing better diagnostic tests is a research priority. The trial will be expanded to 5,000 men next year (Jun ’18). See

  • Deaths rise but revolution in treatment

    The number of UK deaths from prostate cancer has overtaken women’s breast cancer ones for the first time. The latest 2015 figures show there were 11,819 prostate deaths and 11,442 from breast cancer (Feb ’18). See here. But the NHS has launched a one-stop service  in 10 locations to revolutionise cancer treatment. There are none in the South West yet – see here.  More news on the newsletter page. And the New Research page is updated regularly.


A friendly and supportive network that aims to:

We have found that knowledge is of great benefit to the patient. It enables him to play an active part in the decision-making process, for example in selecting the best treatment.

We offer a friendly welcome – join us

Are you just diagnosed, or do you suspect that you may have prostate cancer? Then for friendly peer support and an introduction to Prospect email prospect.bristol@gmail.com or call the Tackle helpline, which will put you in touch with us: 0800 035 5302. You can join us for a small subscription by filling in the PDF membership form on the Contact/Join us page.

This site has been compiled by prostate cancer survivors. We do not claim to have specialist knowledge other than that gained by prostate cancer patients during their treatment.

Protected from despair…

George Monbiot writes in the Guardian that the principles that define a good life protect him from despair, despite a diagnosis of prostate cancer and the ‘grisly’ operation he faces (Mar ’18). See here

We give illustrated talks

Our Mike Broxton gives prostate cancer awareness talks to interested groups, including those with learning disabilities. To arrange a talk, contact prospect.bristol@gmail.com or 0800 035 5302.

Phone volunteers needed

Prostate Cancer UK needs more telephone support volunteers. This  service is provided by trained volunteers who support men affected by prostate cancer and their loved ones, by sharing their experiences of treatments. Apply here.

Having the conversation…

“Manversation” is a campaign to encourage men to speak about prostate cancer, particularly the advanced prostate form. Tackle have collaborated with Orchid, the male cancer charity, and put their name to a video and supporting material on the Manversation website.

Myths debunked and spotting fake cancer news

Ten cancer myths debunked. See here. And also here are six tips to spot cancer fake news

New information for at-risk black men

One in four black men will get prostate cancer – double the overall risk faced by all UK men. Are you are risk? See here

Energise wins award

The exercise-based cancer rehab programme Energise won the Together We Achieve award for 2016. The award, announced at the inaugural Health & Care Awards in March ’17, recognises teams working together to deliver improved patient care and public health. See a video about their work here. For more information on Energise see our Helpful links page.

Regional co-ordinator needed

Tackle need a Regional Co-ordinator for Western Counties. The holder acts as a focal point for communications on region-specific topics between the chairman, Roger Wotton, and member groups in the area. In addition, he or she will participate in occasional meetings or teleconferences. All expenses are reimbursed. If any Prospect member wishes to volunteer, they can email roger.wotton@tackleprostate.org

New research strategy launched

Prostate Cancer UK has launched an ambitious 10-year strategy setting out how it will invest in the most innovative research to create a step change in our knowledge of prostate cancer. See here. And we have more research news here.

Swedish test shows promise

Swedish researchers found a test which is a potentially a game-changing step forward for prostate cancer risk assessment. It involved genetic and protein biomarkers (the S3M) and was much better than PSA alone at detecting potentially dangerous prostate cancers. The Swedish results give compelling evidence the S3M risk assessment model can dramatically cut the number of unnecessary biopsies, without compromising patients’ safety. But Prostate Cancer UK says it’s going to be important to validate this study in a more diverse population before it can accept that it will work elsewhere. It is funding more research to develop a new UK risk assessment tool. These plans are still going full steam ahead, and PCa UK expects to have more to say about this later. See more here.

Tiger or pussycat? That’s the problem

It’s a big problem to tell the difference between slow-growing cancers and aggressive ones. See here. But new research from one of Prostate Cancer UK’s Centres of Excellence could help identify which is which (Oct ’17). See here.

Cancer ‘as unique as fingerprints’

Each person’s cancer is as unique as their fingerprints, said Professor Gillies McKenna, Director of the CRUK/MCR Oxford Institute for Radiation Oncology. This created an opportunity for more precise treatment.

  • Know your risk

    Prostate Cancer UK has a new infographic and booklets.

    Exchange information

    www.myprostate.eu is now also available in English and prostate cancer patients can exchange information and help each other with treatment decisions.

  • Help with treatment choices

    Get enhanced guidance on treatment options, thanks to a checklist developed by researchers (Jun ’17). See. More help here. And why it’s difficult to choose among treatment options (Jul ’17). See. Men with early stage prostate cancer wishing to preserve sexual function while on treatment do not always make the right choices. See

  • Buddies offer home support

    This Macmillan service offers support for adult cancer patients in their homes in Bristol, North Somerset and South Gloucestershire for up to 12 weeks.

    Ring 07543 248714 or email bristolbuddies@macmillan.org.uk